I have a Ph.D. in organic chemistry and over a decade of expertise in drug discovery research within the pharmaceutical industry, both as an expert in computational chemistry and as a manager/project team leader. In 2010, I was co-founding the Chemical Biology Consortium Sweden (CBCS); a national research infrastructure in chemical biology providing expertise in assay development and small molecule screening, and follow up medicinal/computational chemistry support for academic researchers in Sweden, (www.cbcs.se).
Since 2017 I has been the managing director of this national research infrastructure. Based on funding from the Swedish research council, CBCS is a distributed and coordinated infrastructure with activities at six universities around Sweden with a running budget of about 40 MSEK and 24 full-time employees supporting approximately 50 research groups per year.
Together with the Crispr Functional Genomics unit and the Chemical Proteomics unit, CBCS creates a unique multidisciplinary platform at the Science for Life Laboratory.
Group Members:
Hanna Axelsson
Francesco Massai
Kun QIan
Bartlomiej Porebski
Martin Haraldsson
Tobias Koolmeister
Michaela Vallin
Flavio Ballante
Bruna Clemens
Mats Dahlberg
Åsa Slevin
Maria Adolfsson
Elisabeth Olsson